The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cells

被引:11
作者
Dar, Javid A. [1 ,4 ]
Masoodi, Khalid Z. [1 ]
Eisermann, Kurtis [1 ]
Isharwal, Sudhir [1 ]
Ai, Junkui [1 ]
Pascal, Laura E. [1 ]
Nelson, Joel B. [1 ,3 ]
Wang, Zhou [1 ,2 ,3 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15232 USA
[2] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15232 USA
[4] King Saud Univ, Coll Sci, Cent Lab, Riyadh Ksa 11451, Saudi Arabia
基金
美国国家卫生研究院;
关键词
AMINO-ACID SUBSTITUTIONS; DNA-BINDING DOMAIN; TRANSCRIPTIONAL ACTIVATION; TRANSACTIVATION DOMAIN; INSENSITIVITY SYNDROME; COMPLEMENTARY-DNA; HSP90; INHIBITOR; LIGAND; MUTATION; IDENTIFICATION;
D O I
10.1016/j.jsbmb.2014.03.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Androgen-independent nuclear localization is required for androgen receptor (AR) transactivation in castration-resistant prostate cancer (CRPC) and should be a key step leading to castration resistance. However, mechanism(s) leading to androgen-independent AR nuclear localization are poorly understood. Since the N-terminal domain (NTD) of AR plays a role in transactivation under androgen-depleted conditions, we investigated the role of the NTD in AR nuclear localization in CRPC. Deletion mutagenesis was used to identify amino acid sequences in the NTD essential for its androgen-independent nuclear localization in C4-2, a widely used CRPC cell line. Deletion mutants of AR tagged with green fluorescent protein (GFP) at the 5'-end were generated and their signal distribution was investigated in C4-2 cells by fluorescent microscopy. Our results showed that the region of a.a. 294-556 was required for androgen-independent AR nuclear localization whereas a.a. 1-293 mediates Hsp90 regulation of AR nuclear localization in CRPC cells. Although the region of a.a. 294-556 does not contain a nuclear import signal, it was able to enhance DHT-induced import of the ligand binding domain (LBD). Also, transactivation of the NTD could be uncoupled from its modulation of AR nuclear localization in C4-2 cells. These observations suggest an important role of the NTD in AR intracellular trafficking and androgen-independent AR nuclear localization in CRPC cells. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:473 / 480
页数:8
相关论文
共 50 条
  • [11] Targeting persistent androgen receptor signaling in castration-resistant prostate cancer
    Graham, Laura
    Schweizer, Michael T.
    MEDICAL ONCOLOGY, 2016, 33 (05)
  • [12] Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer
    Russo, Joshua W.
    Liu, Xiaming
    Ye, Huihui
    Calagua, Carla
    Chen, Sen
    Voznesensky, Olga
    Condulis, James
    Ma, Fen
    Taplin, Mary-Ellen
    Einstein, David J.
    Balk, Steven P.
    Chen, Shaoyong
    CANCER LETTERS, 2018, 438 : 97 - 104
  • [13] Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
    Lallous, Nada
    Dalal, Kush
    Cherkasov, Artem
    Rennie, Paul S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (06) : 12496 - 12519
  • [14] Androgen Receptor Targeting Drugs in Castration-Resistant Prostate Cancer and Mechanisms of Resistance
    Crona, D. J.
    Milowsky, M. I.
    Whang, Y. E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 98 (06) : 582 - 589
  • [15] Putting the brakes on continued androgen receptor signaling in castration-resistant prostate cancer
    Eichholz, Andrew
    Ferraldeschi, Roberta
    Attard, Gerhardt
    de Bono, Johann S.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 360 (1-2) : 68 - 75
  • [16] Inhibition of Androgen Receptor Nuclear Localization and Castration-Resistant Prostate Tumor Growth by Pyrroloimidazole-based Small Molecules
    Masoodi, Khalid Z.
    Xu, Yadong
    Dar, Javid A.
    Eisermann, Kurtis
    Pascal, Laura E.
    Parrinello, Erica
    Ai, Junkui
    Johnston, Paul A.
    Nelson, Joel B.
    Wipf, Peter
    Wang, Zhou
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (10) : 2120 - 2129
  • [17] N-terminal domain of the androgen receptor contains a region that can promote cytoplasmic localization
    Dar, Javid A.
    Eisermann, Kurtis
    Masoodi, Khalid Z.
    Ai, Junkui
    Wang, Dan
    Severance, Tyler
    Sampath-Kumar, Sharanya D.
    Wang, Zhou
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2014, 139 : 16 - 24
  • [18] Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer
    Antonarakis, Emmanuel S.
    Chandhasin, Chandtip
    Osbourne, Erica
    Luo, Jun
    Sadar, Marianne D.
    Perabo, Frank
    ONCOLOGIST, 2016, 21 (12) : 1427 - 1435
  • [19] The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man
    Sharma, Naomi L.
    Massie, Charlie E.
    Ramos-Montoya, Antonio
    Zecchini, Vincent
    Scott, Helen E.
    Lamb, Alastair D.
    MacArthur, Stewart
    Stark, Rory
    Warren, Anne Y.
    Mills, Ian G.
    Neal, David E.
    CANCER CELL, 2013, 23 (01) : 35 - 47
  • [20] Hydrazinobenzoylcurcumin inhibits androgen receptor activity and growth of castration-resistant prostate cancer in mice
    Wu, Min
    Kim, Sahn-Ho
    Datta, Indrani
    Levin, Albert
    Dyson, Gregory
    Li, Jing
    Kaypee, Stephanie
    Swamy, M. Mahadeva
    Gupta, Nilesh
    Kwon, Ho Jeong
    Menon, Mani
    Kundu, Tapas K.
    Reddy, G. Prem-Veer
    ONCOTARGET, 2015, 6 (08): : 6136 - 6150